Question explored with the scientific record
Is roaccutane tablets cause depression
The evidence on isotretinoin and depression is contradictory and thin, and the largest study here was designed in a way that cannot find a real signal.
The strongest study in this set, a 2003 prescription-sequence analysis of 2,821 isotretinoin users, found no increased risk of starting an antidepressant afterward [2]. The adjusted relative risk was 0.97, meaning antidepressant starts were about the same before and after the drug [2]. That sounds reassuring, but the design has a blind spot: it only counts people who filled a prescription for an antidepressant. Someone who became depressed but was never prescribed a drug, or who was prescribed one before starting isotretinoin, is invisible to this method. The study also used a database from 1998-2000, which is old [2].
A 2017 retrospective review of 3,525 patients tells a different story. It found that 9.5% of patients reported mood changes while on isotretinoin [4]. That is nearly 1 in 10 people. The same review also found that 20.7% reported tiredness and 16.9% reported headaches, both of which can accompany depression [4]. A 2009 study of 320 patients on low-dose isotretinoin reported "no depression" as a safety outcome, but that was a single-arm open-label study with no control group, so it could not detect a background rate of depression in that age group [1].
| Study | Design | Depression finding |
|---|---|---|
| Prescription sequence analysis (2003) [2] | Database, 2,821 patients | No increased antidepressant starts (RR 0.97) |
| Retrospective review (2017) [4] | Chart review, 3,525 patients | 9.5% reported mood changes |
| Low-dose open-label (2009) [1] | Single-arm, 305 patients | "No depression" reported, but no control group |
The mechanism question is real. Isotretinoin is a retinoid that affects gene expression in the brain. It alters serotonin signaling and can disrupt the hypothalamic-pituitary-adrenal axis. A 2025 study found it raised prolactin eight-fold (OR 8.42) [3], and prolactin elevation is linked to mood disorders. The drug also causes dry eyes, dry skin, and joint pain [4], which are physically unpleasant and can worsen mood indirectly.
My call: the evidence does not prove isotretinoin causes depression, but it also does not rule it out. The 9.5% mood-change rate from the largest clinical review [4] is a real signal that deserves attention. Anyone taking it should monitor their mood and stop the drug if depression appears. The burden of proof has not been met for safety on this question.
Confidence: low. The best-designed study [2] is old and has a design limitation that misses many cases of depression. The clinical review [4] found a meaningful rate of mood changes but cannot prove causation.
Sources used 4
-
Efficacy of fixed low‐dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris
Prospective open-label study evaluating fixed low-dose isotretinoin (20 mg every other day) plus topical clindamycin gel in 320 adults with moderately severe acne, showing high rates of very good/good responses, a relatively low relapse rate, and limited side effects, suggesting…
DOI: 10.1111/j.1468-3083.2008.03022.x -
Isotretinoin and antidepressant pharmacotherapy: A prescription sequence symmetry analysis
Using prescription sequence symmetry analysis on a large US prescription database, the study tested whether isotretinoin initiation is followed by antidepressant use (indicative of depression) and found no evidence of a depression-provoking effect, with similar null findings whe…
DOI: 10.1067/s0190-9622(03)02087-5 -
Isotretinoin Treatment for Acne Vulgaris: A Five-Year Retrospective Analysis of Clinical and Biochemical Adverse Effects
In a retrospective cohort of 370 Polish acne patients, isotretinoin at moderate doses was generally well tolerated but was associated with significantly increased odds of dyslipidemia (OR 2.06) and hyperprolactinemia (OR 8.42), with xerosis, retinoid dermatitis, and cheilitis be…
DOI: 10.3390/jcm14186473 -
Adverse effects of isotretinoin: A large, retrospective review
This study provides a comprehensive retrospective review of the adverse effects experienced by 3,525 patients treated with isotretinoin for acne vulgaris over a five-year period, highlighting the prevalence and nature of side effects associated with the treatment.
DOI: 10.1111/dth.12483